Bio & Pharma
Bio & Pharma
Samsung targets gene therapy sector through US investments
Feb 27, 2024 (Gmt+09:00)
-
Bio & Pharma
SK C&C wins Korea’s nod for brain infarct diagnosis AI solution
SK Inc C&C (SK C&C), the information technology service unit of South Korea’s SK Group, said on Thursday it has secured medical device ...
Feb 22, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis to supply Hadlima to US government
South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and development...
Feb 21, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combines...
Feb 19, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharm targets $311 mn for Cenobamate US sales
South Korea's SK Biopharmaceuticals targeted 416 billion won ($311 million) for its epilepsy treatment Cenobamate in the US market this year. SK Biop...
Feb 16, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) to...
Feb 15, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong gets stem cell facility license in Indonesia
South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational ...
Feb 13, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) servi...
Feb 07, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the b...
Feb 07, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastuz...
Feb 05, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Kakao launches AI-based blood sugar management solution
South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digit...
Feb 01, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)....
Jan 24, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clini...
Jan 22, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Biopharma M&As: Next big thing for South Korean manufacturers
When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. la...
Jan 22, 2024 (Gmt+09:00)
4 Min read -
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries ...
Jan 18, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strain...
Jan 17, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its ...
Jan 17, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Roche to use Biodyne’s tech for cervical cancer diagnostic kits
Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne ...
Jan 16, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion Holdings eyes Nasdaq IPO by early 2025: chairman
South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the ...
Jan 16, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Agenc...
Jan 15, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment o...
Jan 12, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion revises up earnings goals to overtake Amgen
Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical comp...
Jan 11, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repla...
Jan 10, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Korea's JLK targets AI-based stroke care market in US
South Korea’s JLK Inc., an AI-based stroke care platform maker, will go all out to build its foothold in the US this year, aiming to lift its s...
Jan 10, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis K...
Jan 10, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung eyes biotech investments via Flagship Pioneering
Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Flag...
Jan 09, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting injec...
Jan 05, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech ...
Jan 05, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize th...
Jan 04, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Medytox establishes US subsidiary Luvantas
South Korean pharmaceutical company Medytox Inc. announced on Wednesday that its establishment of the US subsidiary Luvantas.The goal is the global m...
Jan 03, 2024 (Gmt+09:00)
1 Min read
Hidden Champions
-
Point Mobile
Published: Sep 14, 2021
Last updated: May 10, 2022
-
DCM
Published: Dec 09, 2022
Last updated: Jan 30, 2023
-
T-Robotics
Published: Mar 25, 2021
Last updated: Jan 30, 2023
-
Jong Ie Nara
Published: May 26, 2021
Last updated: Apr 15, 2022
-
3G Technologies
Published: Sep 25, 2020
Last updated: Jul 06, 2021
Future Unicorns
-
BJ BIOCHEM
Published: Oct 21, 2022
Last updated: Nov 04, 2022
-
iCore
Published: Oct 07, 2022
Last updated: Apr 17, 2023
-
SuperBin
Published: Nov 30, 2021
Last updated: May 06, 2022
-
Sandbox Network
Published: Mar 22, 2021
Last updated: Jul 23, 2021
-
Wisely
Published: Sep 20, 2020
Last updated: May 25, 2023
Latest News